Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI
Wayne L Monsky1, Bedro Jin, Chris Molloy
1University of California Davis Medical Center, Department of Radiology, Sacramento, CA, USA. wemonsky@msn.com
Background:
Response Evaluation Criteria in Solid Tumors (RECIST)-defined measurements are limited when evaluating soft tissue sarcoma (STS) response to therapy. Histopathological assessment of STS response requires a determination of necrosis following resection. A novel semi-automated technique for volumetric measurement of tumor necrosis, using enhanced magnetic resonance imaging (CE-MRI), is described.
Patients And Methods:
Eighteen patients with STS were treated with neoadjuvant therapy and then resected. CE-MRI, obtained prior to resection, were evaluated by two observers using semi-automated segmentation. Tumor volume and percent necrosis was compared with histology and RECIST measurements.
Results:
The median percent necrosis, determined histologically and from CE-MRI, was 71.9% and 67.8%, respectively. Accuracy of these semi-automated measurements was confirmed, being statistically similar to those obtained at histopathological assessment of the resected tumor. High Intra-class correlation co-efficients suggest good inter-observer reproducibility. Tumor necrosis did not correlate with the RECIST measurements.
Conclusion:
Semi-automated determination of tumor volume and necrosis, using CE-MRI, is suggested to be accurate and reproducible.
Insights
A new semi-automated method using contrast-enhanced magnetic resonance imaging (CE-MRI) accurately measures tumor necrosis in soft tissue sarcoma (STS). This technique offers reproducible results comparable to traditional histopathology.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Current Response Evaluation Criteria in Solid Tumors (RECIST) have limitations in assessing soft tissue sarcoma (STS) treatment response.
- Histopathological assessment of necrosis post-resection is crucial for evaluating STS response.
- A novel semi-automated technique using contrast-enhanced magnetic resonance imaging (CE-MRI) for volumetric tumor necrosis measurement is introduced.
Purpose of the Study:
- To evaluate the accuracy and reproducibility of a semi-automated CE-MRI technique for measuring tumor necrosis in STS.
- To compare CE-MRI-based necrosis measurements with histopathological findings and RECIST criteria.
Main Methods:
- Eighteen patients with STS underwent neoadjuvant therapy followed by resection.
- Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were acquired before resection.
- Two observers performed semi-automated segmentation on CE-MRI scans to determine tumor volume and percent necrosis.
- Measurements were compared with post-operative histopathology and RECIST criteria.
Main Results:
- Median percent necrosis by histology was 71.9%, and by CE-MRI was 67.8%.
- CE-MRI measurements showed statistical similarity to histopathological assessment, confirming accuracy.
- High intra-class correlation coefficients indicated good inter-observer reproducibility.
- Tumor necrosis measurements did not correlate with RECIST criteria.
Conclusions:
- Semi-automated determination of tumor volume and necrosis using CE-MRI is accurate.
- The CE-MRI technique demonstrates good reproducibility for assessing tumor necrosis in STS.
- This method offers a valuable alternative or adjunct to traditional assessment methods.
More Related Videos
10:25A Dorsal Skinfold Window Chamber Tumor Mouse Model for Combined Intravital Microscopy and Magnetic Resonance Imaging in Translational Cancer Research
Published on: April 12, 2024
09:00Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
